Physician Data Query

Last uploaded: January 31, 2024
Preferred Name

recombinant interferon

Synonyms

rIFN

Definitions

One of a group of recombinant therapeutic glycoprotein cytokines with antiviral, anti-proliferative, and immunomodulating activities. Interferons bind to specific cell-surface receptors, leading to the transcription and translation of genes with interferon-specific response elements (ISREs). The resultant proteins mediate many complex effects, ultimately leading to inhibition of viral protein synthesis and cellular growth, alteration of cellular differentiation, interference with oncogene expression, activation of natural killer cells, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity. The production of endogenous interferons is induced in response to foreign agents such as bacteria, viruses and parasites and to tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C584" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C584" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000040863

altLabel

rIFN

cui

C1522537

Date last modified

2008-04-07

definition

One of a group of recombinant therapeutic glycoprotein cytokines with antiviral, anti-proliferative, and immunomodulating activities. Interferons bind to specific cell-surface receptors, leading to the transcription and translation of genes with interferon-specific response elements (ISREs). The resultant proteins mediate many complex effects, ultimately leading to inhibition of viral protein synthesis and cellular growth, alteration of cellular differentiation, interference with oncogene expression, activation of natural killer cells, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity. The production of endogenous interferons is induced in response to foreign agents such as bacteria, viruses and parasites and to tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C584" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C584" NCI Thesaurus)

Legacy PDQ ID

390

NCI ID

C584

notation

CDR0000040863

ORIG STY

Drug/agent

prefLabel

recombinant interferon

tui

T116

T129

T121

Delete Subject Author Type Created
No notes to display